{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T14:05:33Z","timestamp":1790517933347,"version":"4.1.0"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"3-4","license":[{"start":{"date-parts":[[2004,1,1]],"date-time":"2004-01-01T00:00:00Z","timestamp":1072915200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Familial Cancer"],"published-print":{"date-parts":[[2004]]},"DOI":"10.1007\/s10689-004-9545-z","type":"journal-article","created":{"date-parts":[[2004,10,29]],"date-time":"2004-10-29T21:06:34Z","timestamp":1099083994000},"page":"201-206","source":"Crossref","is-referenced-by-count":50,"title":["Ashkenazi Jewish genetic disorders"],"prefix":"10.1007","volume":"3","author":[{"given":"Joel","family":"Charrow","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1098\/rspb.1966.0032","volume":"164","author":"H. Harris","year":"1966","unstructured":"Harris H.Enzyme polymorphisms in man.Proc R Soc London Ser B Biol Sci 1966;164:298-310.","journal-title":"Proc R Soc London Ser B Biol Sci"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1136\/bmj.1.4857.290","volume":"i","author":"AC. Allison","year":"1954","unstructured":"Allison AC.Protection afforded by sickle cell trait against subtertian malarial infection.BMJ 1954;i:290.","journal-title":"BMJ"},{"key":"CR3","first-page":"377","volume-title":"Advances in Human Genetics","author":"GA. Grabowski","year":"1993","unstructured":"Grabowski GA.Gaucher disease:enzymology,genetics,and treatment.In Harris H, Hirschhorn K (eds):Advances in Human Genetics.New York: Plenum Press 1993;377-441."},{"key":"CR4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jpeds.2003.10.067","volume":"144","author":"J Charrow","year":"2004","unstructured":"Charrow J, Andersson H, Kaplan P et al.Enzyme replacement therapy and monitoring for children with type 1 Gaucher disease: consensus recommendations.J Pediatr 2004;144:1-9.","journal-title":"J Pediatr"},{"key":"CR5","first-page":"3827","volume-title":"The Metabolic and Molecular Basis of Inherited Disease","author":"RA Gravel","year":"2001","unstructured":"Gravel RA, Kaback MM, Proia RL et al.The GM2 gangliosidoses.In Scriver CR, Beaudet AL, Sly WS, Valle D (eds):The Metabolic and Molecular Basis of Inherited Disease,8th edition. New York: McGraw-Hill 2001;3827-76.","edition":"8th edition"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"6388","DOI":"10.1073\/pnas.96.11.6388","volume":"96","author":"M Jeyakumar","year":"1999","unstructured":"Jeyakumar M, Butters TD, Cortina-Borja M et al.Delayed symptom onset and increased life expectancy in Sandhoff disease mice treated with N-butyldeoxynojirimycin.Proc Natl Acad Sci USA 1999;96:6388-93.","journal-title":"Proc Natl Acad Sci USA"},{"key":"CR7","first-page":"472","volume":"4","author":"RH. Lachmann","year":"2003","unstructured":"Lachmann RH. Miglustat.Oxford GlycoSciences\/Actelion.Curr Opin Invest Drugs 2003;4:472-9.","journal-title":"Curr Opin Invest Drugs"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1093\/brain\/awf090","volume":"125","author":"AH. Nemeth","year":"2002","unstructured":"Nemeth AH. The genetics of primary dystonias and related disorders.Brain 2002;125:695-721.","journal-title":"Brain"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1002\/ana.410360514","volume":"36","author":"SB Bressman","year":"1994","unstructured":"Bressman SB, de Leon D, Kramer PL et al.Dystonia in Ashkenazi Jews:clinical characterization of a founder mutation.Ann Neurol 1994;36:771-7.","journal-title":"Ann Neurol"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0065-2660(01)44087-9","volume":"44","author":"J Ekstein","year":"2001","unstructured":"Ekstein J, Katzenstein H.The Dor Yeshorim story:community-based carrier screening for Tay-Sachs disease.Adv Genet 2001;44: 297-310.","journal-title":"Adv Genet"}],"container-title":["Familial Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-004-9545-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10689-004-9545-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-004-9545-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T17:45:53Z","timestamp":1559238353000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10689-004-9545-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004]]},"references-count":10,"journal-issue":{"issue":"3-4","published-print":{"date-parts":[[2004]]}},"alternative-id":["5379545"],"URL":"https:\/\/doi.org\/10.1007\/s10689-004-9545-z","relation":{},"ISSN":["1389-9600","1573-7292"],"issn-type":[{"value":"1389-9600","type":"print"},{"value":"1573-7292","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004]]}}}